Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan · Delayed Price · Currency is TWD 63.40
-0.10 (-0.16%)
Aug 19, 2026, 9:58 AM CST
Shine-On BioMedical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -181.72 | -110.29 | -118.89 | -37.17 | -19.54 | -11.24 |
Depreciation & Amortization | 2.14 | 2.07 | 1.87 | 1.69 | 1.52 | 0.82 |
Other Amortization | - | - | 0.32 | 0.23 | 0.11 | 0.03 |
Loss (Gain) From Sale of Assets | - | - | 0.41 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | -0.11 | - | - | - |
Other Operating Activities | 0.03 | 0.36 | 0.18 | 1.36 | -3.43 | - |
Change in Accounts Receivable | - | - | 10 | -10 | - | - |
Change in Accounts Payable | - | - | -2.86 | 2.86 | - | 2.08 |
Change in Other Net Operating Assets | 30.46 | -6.88 | 17.62 | 14.15 | -0.31 | -0.14 |
Operating Cash Flow | -143.38 | -114.75 | -91.45 | -26.88 | -21.66 | -8.46 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.04 | -0.03 | -0.11 | -0.07 | -0.48 | -2.25 |
Sale (Purchase) of Intangibles | -0.01 | -1.01 | -0.5 | -0.59 | -2.3 | -1.69 |
Investment in Securities | 189 | 126 | 36.11 | -242 | -712 | -108 |
Other Investing Activities | -3.07 | -4.43 | -0.14 | -0.6 | - | -0.38 |
Investing Cash Flow | 185.88 | 120.53 | 35.36 | -243.26 | -714.78 | -112.32 |
Long-Term Debt Repaid | - | -1.27 | -1.28 | -0.99 | -0.99 | - |
Total Debt Repaid | -1.32 | -1.27 | -1.28 | -0.99 | -0.99 | -0.58 |
Net Debt Issued (Repaid) | -1.32 | -1.27 | -1.28 | -0.99 | -0.99 | -0.58 |
Issuance of Common Stock | - | - | - | - | 285.6 | 1,221 |
Financing Cash Flow | -1.32 | -1.27 | -1.28 | -0.99 | 284.61 | 1,221 |
Net Cash Flow | 41.18 | 4.51 | -57.37 | -271.13 | -451.83 | 1,100 |
Free Cash Flow | -143.42 | -114.78 | -91.56 | -26.95 | -22.14 | -10.71 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -283.34% | -382.59% | - | -282.94% | - | - |
Free Cash Flow Per Share | -2.87 | -2.30 | -1.84 | -0.54 | -0.49 | -0.58 |
Levered Free Cash Flow | -78.54 | -78.85 | -58.86 | -31.8 | -14.29 | - |
Unlevered Free Cash Flow | -78.53 | -78.83 | -58.84 | -31.79 | -14.28 | - |
Cash Interest Paid | - | - | - | - | - | 0.02 |
Cash Income Tax Paid | - | -0.53 | 0.24 | 1.1 | 0.27 | - |
Change in Working Capital | 36.17 | -6.88 | 24.77 | 7.01 | -0.31 | 1.93 |